Ratay Michelle L, Bellotti Elena, Gottardi Riccardo, Little Steven R
Department of Bioengineering, University of Pittsburgh, 427 Benedum Hall 3700 O'Hara Street, Pittsburgh, PA, 15261, USA.
Department of Chemical Engineering, University of Pittsburgh, 427 Benedum Hall 3700 O'Hara Street, Pittsburgh, PA, 15261, USA.
Adv Healthc Mater. 2017 Dec;6(23). doi: 10.1002/adhm.201700733. Epub 2017 Oct 16.
Dry eye disease, age-related macular degeneration, and uveitis are ocular diseases that significantly affect the quality of life of millions of people each year. In these diseases, the action of chemokines, proinflammatory cytokines, and immune cells drives a local inflammatory response that results in ocular tissue damage. Multiple therapeutic strategies are developed to either address the symptoms or abate the underlying cause of these diseases. Herein, the challenges to deliver drugs to the relevant location in the eye for each of these diseases are reviewed along with current and innovative therapeutic approaches that attempt to restore homeostasis within the ocular microenvironment.
干眼症、年龄相关性黄斑变性和葡萄膜炎是每年严重影响数百万人生活质量的眼部疾病。在这些疾病中,趋化因子、促炎细胞因子和免疫细胞的作用引发局部炎症反应,导致眼部组织损伤。人们开发了多种治疗策略来缓解这些疾病的症状或消除其根本病因。本文综述了针对这些疾病将药物递送至眼部相关部位所面临的挑战,以及试图恢复眼部微环境内稳态的现有和创新治疗方法。